ArticleTherapeutics and clinical risk management2018

Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17.

Hiromichi Yamane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.